Who founded PathogenDx?

PathogenDx was founded by Michael Hogan, Milan Patel in 2015.

Who are PathogenDx's investors?

PathogenDx's investors include 7thirty, Altitude Investment Management, Salveo Capital.

How much funding has PathogenDx raised?

PathogenDx has disclosed $675K raised across 1 round.

Where is PathogenDx headquartered?

PathogenDx is headquartered in Scottsdale, US.

PathogenDx

Scottsdale, US · Founded 2015 · Delaware corporation · 3 known investors

pathogendx.com ↗

PathogenDx provides molecular pathogen detection assays using proprietary D3 Technology for rapid, multiplexed identification of bacterial, fungal, and viral pathogens in food, agricultural, clinical, and environmental samples.

BiotechFoodTechMedical Devices

Founders & leadership

PathogenDx was founded in 2015 by Michael Hogan and Milan Patel.

Michael HoganCSO

Milan PatelCEO

Eric LachanceCOO

Investors · 3

7thirtyBoulder · $100K – $1M

Altitude Investment Management

Salveo CapitalNorthbrook

Reported raises · per SEC filings

Form D private placements

$675K disclosed across 1 round · 2016

▶$675KraisedApr 2016 · 4 investors · Biotechnology

Officers, directors & promoters on the filing

Eric LachanceExecutive Officer, Director
Michael HoganExecutive Officer, Director
Milan PatelExecutive Officer, Director

Offering amount: $1.2M
Amount sold: $675K
Minimum investment: $50K
First sale: Apr 2016
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 05

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Gendx20 shared keywordsGenDx is a molecular diagnostics company specializing in HLA typing and other reagents and software for pre- and post-transplant testing in diagnostic laboratories. It serves the transplantation and personalized healthcare field, offering NGS-based HLA typing products, software, and educational support.

Genedx15 shared keywordsGeneDx provides genetic testing for rare and inherited conditions, including exome, genome, trio, and prenatal sequencing, paired with clinical interpretation and a large rare disease dataset. It serves clinicians, patients, and biopharma partners to support earlier diagnoses and precision medicine.

CareDx14 shared keywordsCareDx provides molecular diagnostic testing, workflow software, patient support, and pharmacy services for care teams working in transplant, cell therapy, and specialty oncology. Its products support rejection monitoring and complex care management in precision medicine.

Medicinalgenomics14 shared keywordsMedicinal Genomics develops qPCR-based testing technologies used to verify product safety and regulatory compliance. Its tools serve testing labs, manufacturers, and brands.

Companies competing with PathogenDx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does PathogenDx do?: PathogenDx provides molecular pathogen detection assays using proprietary D3 Technology for rapid, multiplexed identification of bacterial, fungal, and viral pathogens in food, agricultural, clinical, and environmental samples.
Who founded PathogenDx?: PathogenDx was founded by Michael Hogan, Milan Patel in 2015.
Who are PathogenDx's investors?: PathogenDx's investors include 7thirty, Altitude Investment Management, Salveo Capital.
How much funding has PathogenDx raised?: PathogenDx has disclosed $675K raised across 1 round.
Where is PathogenDx headquartered?: PathogenDx is headquartered in Scottsdale, US.